Open incisional biopsy of superficial soft tissue in the thigh or knee area, requiring a skin incision to obtain tissue for pathologic analysis.
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $274.89
- Total RVUs
- 8.23
- Global, days
- 10
- Region
- Knee
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Confirm that an incision was made — needle-only approaches do not support 27323
- Explicitly document the lesion's relationship to the deep fascia (superficial vs. deep) to justify the level selected
- Record lesion size, location (e.g., anterior thigh, medial knee area), and laterality (left vs. right)
- Document pre- and postoperative diagnosis, including any clinical suspicion driving the biopsy indication
- Note whether imaging guidance was used; if so, document the guidance modality separately for add-on billing
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 27323 covers an open, incisional biopsy of superficial soft tissue located in the thigh or knee region. The surgeon makes a skin incision, dissects to the target lesion, and removes a tissue sample — distinguishing this from needle-based techniques. If no incision is made and the surgeon uses a needle (core or fine needle), report 20206 instead. That distinction is the most common coding error on thigh soft tissue biopsies.
The superficial designation matters: 27323 applies when the lesion is above the deep fascia. Deep soft tissue biopsy of the same region — below the fascia or intramuscular — is reported with 27324. Operative notes that fail to document the relationship of the mass to the deep fascia give auditors and payers grounds to question the level billed.
The global period is 10 days. Routine follow-up within that window is included. If imaging guidance (e.g., ultrasound) is used to direct needle placement, the guidance code is separately billable — but again, once you add US-guided needle placement, confirm whether 27323 is still the right base code versus 20206.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 2.27 |
| Practice expense RVU | 5.66 |
| Malpractice RVU | 0.3 |
| Total RVU | 8.23 |
| Medicare national rate | $274.89 |
| Global period | 10 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $274.89 |
HOPD (APC 5072) Hospital outpatient department | $1,687.37 |
ASC (PI A2) Ambulatory surgical center (freestanding) | $742.04 |
Common denial reasons
The recurring reasons claims for CPT 27323 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Downcoded to 20206 when operative note describes needle biopsy technique rather than open incisional approach
- Upcoded challenge to 27324 rejected when fascia depth is not documented and payer defaults to superficial
- Missing laterality modifier causes claim suspension or rejection under payers requiring LT/RT on unilateral procedures
- Lack of medical necessity documentation when pathology indication (mass characteristics, prior imaging) is absent from the note
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between 27323 and 20206 for a thigh biopsy?
02When should I use 27324 instead of 27323?
03Do I need a laterality modifier on 27323?
04Can I separately bill ultrasound guidance when performing this biopsy?
05What is the global period for 27323, and what does it include?
06Why does dermatology show as a top-billing specialty for 27323?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02aapc.comhttps://www.aapc.com/codes/cpt-codes/27323
- 03findacode.comhttps://www.findacode.com/cpt/27323-cpt-code.html
- 04genhealth.aihttps://genhealth.ai/code/cpt4/27323-biopsy-soft-tissue-of-thigh-or-knee-area-superficial
- 05mdclarity.comhttps://www.mdclarity.com/cpt-code/27323
Mira AI Scribe
Mira's AI scribe captures the surgical approach (incisional vs. needle), the lesion's anatomic depth relative to the deep fascia, size and location of the mass, and laterality from the operative dictation. This prevents the two most common downcodes on 27323: miscoding an open biopsy as 20206 (needle) and losing the superficial vs. deep distinction that separates 27323 from 27324.
See how Mira captures CPT 27323 documentation